Samsung Biologics Co Ltd
KRX:207940
Wall Street
Price Targets
Price Targets Summary
Samsung Biologics Co Ltd
According to Wall Street analysts, the average 1-year price target for
Samsung Biologics Co Ltd
is 2 266 567.5166 KRW
with a low forecast of 2 018 784.8009 KRW and a high forecast of 2 730 000 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Samsung Biologics Co Ltd's stock price target?
Price Target
2 266 567.5166
KRW
According to Wall Street analysts, the average 1-year price target for
Samsung Biologics Co Ltd
is 2 266 567.5166 KRW
with a low forecast of 2 018 784.8009 KRW and a high forecast of 2 730 000 KRW.
What is Samsung Biologics Co Ltd's Revenue forecast?
Projected CAGR
14%
For the last 10 years the
compound annual growth rate for
Samsung Biologics Co Ltd's revenue is
46%.
The projected
CAGR
for the next 4 years is
14%.
What is Samsung Biologics Co Ltd's Operating Income forecast?
Projected CAGR
16%
The
compound annual growth rate
of Samsung Biologics Co Ltd's operating income for the next 4 years is
16%.
What is Samsung Biologics Co Ltd's Net Income forecast?
Projected CAGR
27%
The
compound annual growth rate
of Samsung Biologics Co Ltd's net income for the next 3 years is
27%.
